BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10506298)

  • 1. Health care utilization and costs among patients treated for bipolar disorder in an insured population.
    Simon GE; Unützer J
    Psychiatr Serv; 1999 Oct; 50(10):1303-8. PubMed ID: 10506298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care utilization and costs among privately insured patients with bipolar I disorder.
    Bryant-Comstock L; Stender M; Devercelli G
    Bipolar Disord; 2002 Dec; 4(6):398-405. PubMed ID: 12519100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care.
    Stensland MD; Jacobson JG; Nyhuis A
    J Affect Disord; 2007 Aug; 101(1-3):187-93. PubMed ID: 17254637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs associated with attempted suicide among individuals with bipolar disorder.
    Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
    J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct costs of bipolar disorder versus other chronic conditions: an employer-based health plan analysis.
    Williams MD; Shah ND; Wagie AE; Wood DL; Frye MA
    Psychiatr Serv; 2011 Sep; 62(9):1073-8. PubMed ID: 21885587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treated prevalence of bipolar disorder in a large staff-model HMO.
    Unützer J; Simon G; Pabiniak C; Bond K; Katon W
    Psychiatr Serv; 1998 Aug; 49(8):1072-8. PubMed ID: 9712215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of mental health utilization and costs among children in a privately insured population.
    Leslie DL; Rosenheck RA; Horwitz SM
    Health Serv Res; 2001 Apr; 36(1 Pt 1):113-27. PubMed ID: 11324739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifting to outpatient care? Mental health care use and cost under private insurance.
    Leslie DL; Rosenheck R
    Am J Psychiatry; 1999 Aug; 156(8):1250-7. PubMed ID: 10450268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of treating substance abuse patients with and without comorbid psychiatric disorders.
    Hoff RA; Rosenheck RA
    Psychiatr Serv; 1999 Oct; 50(10):1309-15. PubMed ID: 10506299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment use and costs among privately insured youths with diagnoses of bipolar disorder.
    Dusetzina SB; Farley JF; Weinberger M; Gaynes BN; Sleath B; Hansen RA
    Psychiatr Serv; 2012 Oct; 63(10):1019-25. PubMed ID: 22855210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insurance expenditures on bipolar disorder: clinical and parity implications.
    Peele PB; Xu Y; Kupfer DJ
    Am J Psychiatry; 2003 Jul; 160(7):1286-90. PubMed ID: 12832243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of unipolar depression following initial identification of bipolar disorder: a common and costly misdiagnosis.
    Stensland MD; Schultz JF; Frytak JR
    J Clin Psychiatry; 2008 May; 69(5):749-58. PubMed ID: 18363423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders.
    Busch AB; Yoon F; Barry CL; Azzone V; Normand SL; Goldman HH; Huskamp HA
    Am J Psychiatry; 2013 Feb; 170(2):180-7. PubMed ID: 23377639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of health care costs associated with depression and substance abuse in a national sample.
    Druss BG; Rosenheck RA
    Psychiatr Serv; 1999 Feb; 50(2):214-8. PubMed ID: 10030479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of medication choice and comorbid diabetes: the cost of bipolar disorder in a privately insured US population.
    Harley C; Li H; Corey-Lisle P; L'Italien GJ; Carson W
    Soc Psychiatry Psychiatr Epidemiol; 2007 Sep; 42(9):690-7. PubMed ID: 17603740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in mental health insurance benefits and out-of-pocket spending.
    McKusick DR; Mark TL; King EC; Coffey RM; Genuardi J
    J Ment Health Policy Econ; 2002 Jun; 5(2):71-8. PubMed ID: 12529560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effectiveness and cost of a systematic care program for bipolar disorder.
    Simon GE; Ludman EJ; Bauer MS; Unützer J; Operskalski B
    Arch Gen Psychiatry; 2006 May; 63(5):500-8. PubMed ID: 16651507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.
    Bagalman E; Muser E; Choi JC; Durden E; Macfadden W; Haskins JT; Dirani R
    Clin Ther; 2011 Oct; 33(10):1381-1390.e4. PubMed ID: 22000656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical history and costs associated with delayed diagnosis of bipolar disorder.
    Stang PE; Frank C; Kalsekar A; Yood MU; Wells K; Burch S
    MedGenMed; 2006 Apr; 8(2):18. PubMed ID: 16926757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral health insurance parity for federal employees.
    Goldman HH; Frank RG; Burnam MA; Huskamp HA; Ridgely MS; Normand SL; Young AS; Barry CL; Azzone V; Busch AB; Azrin ST; Moran G; Lichtenstein C; Blasinsky M
    N Engl J Med; 2006 Mar; 354(13):1378-86. PubMed ID: 16571881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.